Tag: ARNA

Blue Horseshoe Stocks: CNAT, Options Ideas & Extended Watchlist

Conatus Pharmaceuticals, Inc. CNAT

CNAT is a stock that we first discovered as an FDA play back in early December, when one of the company’s treatments had been granted orphan drug status.  At the time, the stock was trading at less than $5 a share, and by January, we saw a huge run that took it over $14.

It brought a few other swings in the following months, but had fallen to the back burner for quite some time as it consolidated. Yesterday it set off our alarms once again, springing back to life and running hard on heavy volume, so once again CNAT has our full attention.

After reaching as high as 9.90 during yesterday’s session, we’ll be on the lookout for possible dip-and-rip opportunities. We’d like to see support hold in the 8-8.50 range moving forward and if it can do that, chances to score quick strike gains on the bounce could be present.

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

The PBR options chain has been a veritable cash cow for us this year as many of you already know, and we’ll continue to talk about it for as long as it continues to work in our favor. Yesterday was no letdown, as

All of the Call contracts that we’ve been monitoring ($14-15 Weekly Calls and the 07/19 $15 Calls) have been rocking, providing us with several shots at alarmingly high returns.

If PBR breaks over this morning’s pre-market high of 15.90, we may look to roll our strike price up to $16 (Possibly the 07/03 $16’s which closed @ .36 yesterday) and with how far the latest trend has taken us, we wouldn’t be too surprised to see that happen.

Extra Options Idea: Molson Coors Brewing Co. TAP

The TAP October $75 Calls showed an abnormal amount of trading activity yesterday, causing us to raise an eyebrow. Just for good measure, we’re going to throw those contracts up on our radar and monitor the situation.

Extended Watchlist:
KNDI, GERN, ZLCS, REPH, IDN, SNSS, SIGM, ARNA

Blue Horseshoe Stocks: INCC Update, AAPL, NEWL & Extended Watchlist

International Consolidated Companies, Inc. INCC

Our anticipation of a possible dip-and-rip scenario on INCC yesterday proved to be warranted, and the stock actually provided us with a number of intraday swings.

To start the day off, the stock made two significant moves, each time running 25% from .0032-.004. Toward midday we witnessed another dip to .003, and a subsequent rip on up to .0039, adding another 30% in potential gains. Finally, we saw one last swing from .0033-.0039, an 18% move, which brought our possible gains for the session to a cumulative total of 98%

INCC put in quite a good performance for a first day alert, and we’ll monitoring this one as the week progresses for the same type of volatility that offered us those chances to profit on Monday.

Apple, Inc. AAPL

Last Wednesday, we commented on the Apple-Beats rumor, as well as speculating that AAPL could be in for a run-up, and that has certainly come to pass. Our call of 604.40 as a pivot point proved accurate, as we stated that a break of that level had the potential to give way to more significant gains.

That brings us up to yesterday’s session, where AAPL went on to set a new 52-week high at 607.33. We expect AAPL Calls to continue to do well in the midst of this uptrend, and as our regular rteaders are aware, we’ve made astonishing gains from the AAPL Options Chain in the past.


NewLead Holdings Ltd. NEWL

Sometimes in the course of attempting to track to biggest potential gainers, we find that it can take several sessions for a pick to mature. Such was the case with NEWL, as we showed up slightly early to the party. The most important thing, however, was that we showed up.

We began tracking NEWL for a bottom a couple of Fridays ago, and while we were attempting to sniff out a low, the company announced a significant 1-for-50 reverse split. As the stock attempts to normalize following that major development, we are seeing a massive surge in both PPS and volume.

We will definitely be tracking NEWL more closely following this cleaning up of the share structure, as well as other developments that have been recently announced.

Extended Watchlist:
ARX, DNDN, ARNA, TEDU, ONCY, IDN

AAPL, DRHC & Extended Watchlist

Dethrone Royalty Holdings, Inc. DRHC

Our bottom-bounce call of DRHC yesterday was spot-on. The stock pulled back to .0065 before running as high as .0094. In the video chart that we published along with our alert, we stated that we were simply looking for a quick 30-50% move out of DRHC, and that’s exactly what we got.

We like the activity we are seeing from this bottom play and will continue to monitor for subsequent bounces, provided the stock holds above yesterday’s support level of .0065.

Apple, Inc. AAPL

We sincerely hope our recent coverage of Apple calls hasn’t fallen upon deaf ears. We started with the $415 & $420 Calls last Monday, and kept raising our strike price as time progressed and Apple traded higher. On Wednesday, we had lifted it up to the $445’s, $450’s, and were even looking as high as the $455 Calls. The $455′s were as cheap as 2.30 on Friday, and hit a high of 9.80 yesterday, a possible gain of 326%, and that upward trend should continue.

This morning, Apple is trading up pre-market, causing us to once again raise our strike price into the $465 and $470 Calls. That being said, Apple has been on an absolute tear since its last earnings release, steamrolling upward for the past couple of weeks, thus we want to stay on our toes so that we won’t be caught off guard by a reversal. The next key resistance points are likely to be at $469.95, and $484.94. Should it break those levels, there is a gap to fill up to $504.77, as we point out on the chart below.

Extended Watchlist:
MWIP, ARNA, NLS, USU, ONCY, IBIO,

ARNA, VGHI & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

We have been covering ARNA for quite some time, since we learned of the possibility of an FDA approval. Yesterday that became a reality, with everyone and their brother discussing ARNA’s FDA approval, including the talking heads on CNBC. Around midday, the stock was briefly halted, before the announcement was made:

“On June 27, Arena Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved BELVIQ as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adult patients. BELVIQ is the first prescription weight-loss treatment approved by the FDA in 13 Years.”

Shortly following, the stock was reopened for trading, and trade it did! 90.2 million shares, over 4 times the 3mo. average, traded hands. ARNA rose to a high of 13.50. We first alerted ARNA on May 11th, after which time the stock was trading as low as 5.44. That would represent a gain of 148% to yesterday’s high of 13.50.

We feel that once the initial clamor subsides, and the volitility calms a bit, we should see a bit of a pullback, as is to be expected with most astronomical gainers. That being said, the long-term for this stock looks very promising indeed, so while the excitement should begin to die down, our interest in following ARNA moving forward will not.

____

VHGI Holdings, Inc. VHGI

Monday, we stated: “On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce.”

It seems we came to this observation just in nick of time. The stock was as low as .055 following this alert. Since then it has seen a high of .095, equating to a gain of 73%. Those that have been with us for awhile know we are not one hit wonders in most cases when we cover a stock.

We will continue to monitor VHGI as it recovers off of its bottom, and in reality, we would not be shocked to see it return to previous support and higher. When we first covered this play, it ran from .20 to .75, and thus huge gains do not seem out of the realm of possibility for VHGI.

____

Extended Watchlist:

   EBIG, EEDG, AGDY, UNDR

Golden Phoenix Minerals, Inc. – GPXM & Today’s Ext. Watchlist

Golden Phoenix Minerals, Inc. GPXM

GPXM is new to our reports this morning. It caught our eye for a number of reasons, including one heck of a strong chart setup.

Recently, from May to June, the stock ran from .009 to .0328 for a 264% gain. Since that time, we’ve seen a consolidation and we’ve found a level of support at the .015 mark. The stock has been trading in a tight channel in the meantime, bouncing around between .015 and .022. A break of that resistance at .022 could really send this thing shooting back to recent highs in the low .03’s.

The 20DMA is rising toward a Golden Cross with the 50DMA. The RSI is pointed northward, holding above the 50DMA overlay, and appears as if it wants to head toward the powerzone. (Currently 55.98, Powerzone: 70-90)

The Slow STO is hooking up, looking ready for a cross as well. We’d like to see it continue to hold above the 50DMA overlay, which we will take as a sign of strength.

Barchart is currently giving GPXM a Buy Rating

The company also hinted at recent progression in the PR dated June 11th.

____

Extended Watchlist:

   ARNA, EBIG, THWI

Get Our FREE Daily Reports!

SUBSCRIBE